HKEX Insider Activity — 2026-08-26

by hk-insider-activities-daily

🇭🇰 HKEX DI Report — 2026-08-26

🟢 ACCUMULATING — 1276 Jiangsu Hengrui Pharmaceuticals ← GIC, 17.19% (increased by 1.49pp from prior filing) Read: GIC topped up an already large position via an on-exchange purchase worth roughly HK$185M, reinforcing conviction in the name.

🟢 ACCUMULATING — 2359 WuXi AppTec ← JPMorgan, 12.09% (increased by 1.27pp from prior filing) Read: JPMorgan's aggregate long book rose past 12% even though the filing cites an off-exchange sale, suggesting netting across custody/prime-brokerage sub-accounts rather than a directional call.

🟢 ACCUMULATING — 1276 Jiangsu Hengrui Pharmaceuticals ← JPMorgan, 10.69% (increased by 1.10pp from prior filing) Read: A second filer grew its stake to 10.69%, adding to the bullish read from GIC's purchase on the same name.

🆕 NEW ENTRY — 3908 CICC (China International Capital Corporation) - H ← BlackRock, 5.01% (increased by 0.23pp from prior filing) Read: BlackRock's aggregate stake re-crossed the 5% notifiable line as related entities consolidated — a re-filing artifact of a growing position, not a fresh buy trigger.

🆕 NEW ENTRY — 1489 GC Construction Holdings ← Global Line Network Sdn. Bhd., 19.00% (increased by 19.00pp from prior filing) Read: First-ever 5%+ disclosure on a HK$77.9M block, part of a coordinated three-entity group all crossing 19% together (see related filers below).

🆕 NEW ENTRY — 1489 GC Construction Holdings ← United Link Co., Ltd., 19.00% (increased by 19.00pp from prior filing) Read: Same 190M-share block disclosed one level up the ownership chain as a deemed interest.

🆕 NEW ENTRY — 1489 GC Construction Holdings ← Wiselink Co., Ltd., 19.00% (increased by 19.00pp from prior filing) Read: Top of the same chain — three related entities jointly crossing 19% signals a concentrated new controlling block in this small-cap builder.

🆕 NEW ENTRY — 1336 New China Life Insurance - H ← JPMorgan, 5.06% (increased by 0.08pp from prior filing) Read: A bare threshold cross just above 5% — passive-looking rather than an active accumulation call.

🆕 NEW ENTRY — 2696 Shanghai Henlius Biotech - H ← GIC, 5.03% (increased by 0.07pp from prior filing) Read: GIC just tipped over 5% in the biotech name, worth watching for follow-through buying.

🆕 NEW ENTRY — 8176 SuperRobotics Holdings ← Go Treasures Ventures Limited, 29.90% (increased by 29.90pp from prior filing) Read: A near-30% stake disclosed for the first time in this micro-cap puts a large, concentrated holder on the register.

🆕 NEW ENTRY — 8176 SuperRobotics Holdings ← Kin Kwan Holding Group Limited, 29.90% (increased by 29.90pp from prior filing) Read: Same 213.9M-share block reported up the chain from Kin Kwan Holding Group, confirming a single 29.9% controlling interest.

🏢 BUYBACK — 2007 Country Garden Holdings ← JPMorgan, 5.28% (decreased by 1.23pp from prior filing) Read: Issuer buyback of ~573M shares (HK$105M) mechanically trimmed JPMorgan's custodial %, not a sale on its part.

🏢 BUYBACK — 9896 MINISO Group ← The Bank of New York Mellon, 9.52% (decreased by 0.73pp from prior filing) Read: MINISO's ongoing buyback shrank the share base, pulling BNY Mellon's custodial % down with no change in shares actually held.

🏢 BUYBACK — 6031 SANY Heavy Industry - H ← JPMorgan, 12.49% (decreased by 0.61pp from prior filing) Read: Buyback-driven share count reduction (~HK$84.5M repurchased) nudged JPMorgan's percentage down mechanically.

⚙️ OPTION/CONVERSION — 6809 Montage Technology - H ← JPMorgan, 8.96% (decreased by 0.69pp from prior filing) Read: New-share subscription diluted JPMorgan's existing stake; not a directional trading signal.

⚙️ OPTION/CONVERSION — 1489 GC Construction Holdings ← Kok En Gan, 53.90% (decreased by 19.00pp from prior filing) Read: Director subscribed into the same placement tranche that created the new substantial holders above, still controlling a majority-adjacent 53.9% post-dilution.

⚙️ OPTION/CONVERSION — 1489 GC Construction Holdings ← Jumbo Flags Capital Limited, 53.90% (decreased by 19.00pp from prior filing) Read: Related-party vehicle in the same subscription round, holding a controlling 53.9% alongside the director.

⚙️ OPTION/CONVERSION — 2591 Guangzhou Innogen Pharmaceutical ← Korea Investment Holdings, 7.79% (decreased by 0.94pp from prior filing) Read: Subscription-driven dilution trimmed the stake slightly, with underlying shares held unchanged.

⚙️ OPTION/CONVERSION — 2591 Guangzhou Innogen Pharmaceutical ← Korea Investment Partners, 7.79% (decreased by 0.94pp from prior filing) Read: Mirror filing from the affiliated Korea Investment entity in the same placement round.

🔵 MAINTENANCE

• 3223 Ingenic Semiconductor - H ← Guotai Haitong Securities, 23.50% (increased by 23.50pp from prior filing) Read: Reason code 1701 marks this as a securities-lending pool reclassification at the broker (shares shifting between lending buckets), not an open-market trade — the large percentage swing is bookkeeping, not conviction.